{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:23:14Z","timestamp":1783506194037,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NZ Health and Research Council","award":["14-191"],"award-info":[{"award-number":["14-191"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.pcd.2017.07.003","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T20:45:32Z","timestamp":1502225132000},"page":"561-569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9327-2897","authenticated-orcid":false,"given":"Marta Paulino","family":"Silvestre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katya","family":"Volkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonjoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally Diana","family":"Poppitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2017.07.003_bib0005","series-title":"IDF Diabetes Atlas Update Poster","author":"International Diabetes Federation","year":"2015"},{"key":"10.1016\/j.pcd.2017.07.003_bib0010","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4239\/wjd.v6.i2.296","article-title":"Prediabetes diagnosis and treatment: a review","volume":"6","author":"Bansal","year":"2015","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.pcd.2017.07.003_bib0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pcd.2017.07.003_bib0020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.diabres.2004.06.010","article-title":"Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males","volume":"67","author":"Kosaka","year":"2005","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.pcd.2017.07.003_bib0025","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.2337\/diacare.26.12.3230","article-title":"The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity","volume":"26","author":"Lindstrom","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2017.07.003_bib0030","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2337\/diacare.20.4.537","article-title":"Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and diabetes study","volume":"20","author":"Pan","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2017.07.003_bib0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","article-title":"The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)","volume":"49","author":"Ramachandran","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.pcd.2017.07.003_bib0040","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pcd.2017.07.003_bib0045","first-page":"23","article-title":"Prevalence of diagnosed and undiagnosed diabetes and prediabetes in New Zealand: findings from the 2008\/09 Adult Nutrition Survey","volume":"126","author":"Coppell","year":"2013","journal-title":"N. Z. Med. J."},{"key":"10.1016\/j.pcd.2017.07.003_bib0050","series-title":"The Assessment and Management of Cardiovascular Risk","author":"New Zealand Guidelines Group","year":"2003"},{"key":"10.1016\/j.pcd.2017.07.003_bib0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-8703(91)90861-B","article-title":"Cardiovascular disease risk profiles","volume":"121","author":"Anderson","year":"1991","journal-title":"Am. Heart J."},{"key":"10.1016\/j.pcd.2017.07.003_bib0060","series-title":"Global Guideline for Type 2 Diabetes","author":"International Diabetes Federation","year":"2012"},{"key":"10.1016\/j.pcd.2017.07.003_bib0065","first-page":"28","article-title":"Screening for diabetes, impaired glucose tolerance, and cardiovascular risk in primary care: a Northland, New Zealand pilot study","volume":"122","author":"White","year":"2009","journal-title":"N. Z. Med. J."},{"key":"10.1016\/j.pcd.2017.07.003_bib0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S2213-8587(13)70103-7","article-title":"Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): a validation of existing models","volume":"2","author":"Kengne","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.pcd.2017.07.003_bib0075","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2337\/diacare.26.3.725","article-title":"The diabetes risk score: a practical tool to predict type 2 diabetes risk","volume":"26","author":"Lindstrom","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2017.07.003_bib0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3132\/dvdr.2005.011","article-title":"Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome","volume":"2","author":"Saaristo","year":"2005","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"10.1016\/j.pcd.2017.07.003_bib0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3402\/ijch.v66i2.18239","article-title":"National type 2 diabetes prevention programme in Finland: FIN-D2D","volume":"66","author":"Saaristo","year":"2007","journal-title":"Int. J. Circumpolar Health"},{"key":"10.1016\/j.pcd.2017.07.003_bib0090","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/j.1464-5491.2012.03664.x","article-title":"Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study","volume":"29","author":"Hellgren","year":"2012","journal-title":"Diabetic Med. J. Br. Diabetic Assoc."},{"key":"10.1016\/j.pcd.2017.07.003_bib0095","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1055\/s-0028-1087191","article-title":"A more simplified Finnish diabetes risk score for opportunistic screening of undiagnosed type 2 diabetes in a German population with a family history of the metabolic syndrome","volume":"41","author":"Li","year":"2009","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.pcd.2017.07.003_bib0100","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.diabet.2010.09.006","article-title":"Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece","volume":"37","author":"Makrilakis","year":"2011","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.pcd.2017.07.003_bib0105","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.medcli.2011.05.025","article-title":"Validation of the FINDRISC (Finnish Diabetes Risk Score) for prediction of the risk of type 2 diabetes in a population of southern Spain Pizarra Study","volume":"138","author":"Soriguer","year":"2012","journal-title":"Med. Clin."},{"key":"10.1016\/j.pcd.2017.07.003_bib0110","first-page":"67","article-title":"Prevalence of undiagnosed abnormal glucose tolerance in adult patients cared for by general practitioners in Hungary. Results of a risk-stratified screening based on FINDRISC questionnaire","volume":"19","author":"Winkler","year":"2013","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"issue":"6","key":"10.1016\/j.pcd.2017.07.003_bib0115","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3390\/nu9060632","article-title":"PREVIEW: prevention of diabetes through lifestyle Intervention and population studies in Europe and around the World. Design, methods and baseline participant description of an adult cohort enrolled into a 3-year randomized clinical trial","volume":"9","author":"Fogelholm","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.pcd.2017.07.003_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408349508050556","article-title":"Glucose oxidase as an analytical reagent","volume":"25","author":"Raba","year":"1995","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.pcd.2017.07.003_bib0125","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1515\/CCLM.2006.275","article-title":"Approved IFCC recommendation on reporting results for blood glucose: International Federation of Clinical Chemistry and Laboratory Medicine Scientific Division, Working Group on Selective Electrodes and Point-of-Care Testing (IFCC-SD-WG-SEPOCT)","volume":"44","author":"D'Orazio","year":"2006","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.pcd.2017.07.003_bib0130","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","author":"American Diabetes Association","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2017.07.003_bib0135","doi-asserted-by":"crossref","first-page":"e007195","DOI":"10.1136\/bmjopen-2014-007195","article-title":"Validating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol","volume":"5","author":"Salinero-Fort","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.pcd.2017.07.003_bib0140","doi-asserted-by":"crossref","first-page":"e0158489","DOI":"10.1371\/journal.pone.0158489","article-title":"Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a community-based, cross-sectional programme for screening of undiagnosed type 2 diabetes mellitus and dysglycaemia in Madrid, Spain: the SPREDIA-2 study","volume":"11","author":"Salinero-Fort","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pcd.2017.07.003_bib0145","doi-asserted-by":"crossref","first-page":"e97865","DOI":"10.1371\/journal.pone.0097865","article-title":"Evaluation of Finnish Diabetes Risk Score in screening undiagnosed diabetes and prediabetes among U.S. adults by gender and race: NHANES 1999\u20132010","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pcd.2017.07.003_bib0150","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.metabol.2013.10.006","article-title":"An examination of sex and racial\/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score","volume":"63","author":"Gurka","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.pcd.2017.07.003_bib0155","first-page":"U2607","article-title":"Ethnic differences in the prevalence of new and known diabetes mellitus, impaired glucose tolerance, and impaired fasting glucose. Diabetes Heart and Health Survey (DHAH) 2002-2003, Auckland New Zealand","volume":"120","author":"Sundborn","year":"2007","journal-title":"N. Z. Med. J."},{"key":"10.1016\/j.pcd.2017.07.003_bib0160","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","author":"A.D.A","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2017.07.003_bib0165","unstructured":"WHO, World Health Organization Study Group: Diabetes Mellitus, Geneva Technical Report Series Number (1985)."},{"key":"10.1016\/j.pcd.2017.07.003_bib0170","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2337\/db05-1200","article-title":"Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the veterans administration genetic epidemiology study","volume":"55","author":"Abdul-Ghani","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.pcd.2017.07.003_bib0175","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2337\/dc05-2179","article-title":"Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose","volume":"29","author":"Abdul-Ghani","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2017.07.003_bib0180","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2337\/diabetes.53.6.1549","article-title":"Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose","volume":"53","author":"Festa","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.pcd.2017.07.003_bib0185","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.2337\/diabetes.48.11.2197","article-title":"Metabolic characteristics of individuals with impaired fasting glucose and\/or impaired glucose tolerance","volume":"48","author":"Weyer","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.pcd.2017.07.003_bib0190","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.diabres.2007.05.004","article-title":"Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies","volume":"78","author":"Gerstein","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.pcd.2017.07.003_bib0195","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/dmrr.728","article-title":"Predicting the 20-year diabetes incidence rate","volume":"23","author":"Dankner","year":"2007","journal-title":"Diabetes. Metab. Res. Rev."},{"key":"10.1016\/j.pcd.2017.07.003_bib0200","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2337\/diacare.22.3.399","article-title":"Impaired fasting glucose or impaired glucose tolerance What best predicts future diabetes in Mauritius?","volume":"22","author":"Shaw","year":"1999","journal-title":"Diabetes Care"}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991817301158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991817301158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:56:28Z","timestamp":1761695788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991817301158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1751991817301158"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2017.07.003","relation":{},"ISSN":["1751-9918"],"issn-type":[{"value":"1751-9918","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2017.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}